ArticlebioRxiv : the preprint server for biology2025
Therapeutic delivery of albumin-binding siRNA targeting IRS2 to diverse cell types reduces mammary tumor growth.
Claire E Tocheny et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.